BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Form 7 Monthly Progress Report May 2025 Name of Listed Issuer: Trading Symbol: Number of
Novel Graph Neural Network (N-GNN) Model Achieves Superior Accuracy in Early Lung Cancer Detection, Paving
Form 7 Monthly Progress Report May 2025 Name of Listed Issuer: Trading Symbol: Number of
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability
Milestone strengthens transparency and credibility as the Company advances commercialization of its metabolomics technology platform
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2